SESSION XII: HODGKIN LYMPHOMA

Session Chair: Alex Herrera, MD

What Is the Standard for Frontline Advanced Stage Hodgkin Lymphoma? | Alex Herrera, MD | City of Hope, Duarte, California, USA

Approach to Relapsed/Refractory Hodgkin Lymphoma in 2025 | Sarah Rutherford, MD | Weill Cornell Medical College, New York, New York, USA

Oral Abstract | HL-998: First-in-Human, Open-Label, Phase I Study of CD30-Directed Antibody-Drug Conjugate (ADC) With a Topoisomerase 1 Inhibitor Payload, PF-08046044 (35C) in Patients With Relapsed/Refractory Lymphomas: Safety and Preliminary Efficacy From Dose Escalation | Michael A. Spinner, MD | University of California San Francisco, San Francisco, California, USA